Evidence map›Paper›PMID 35510310›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Chitosan-Based Microparticle Encapsulated

Margaret O Ilomuanya, Nkechi V Enwuru, Emmanuella Adenokun, Abigail Fatunmbi, Adebowale Adeluola, Cecilia I Igwilo

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Phage-encoded depolymerases as a strategy for combating multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Margaret O IlomuanyaUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Lagos, NigeriaORCID 0000-0001-8819-1937
Nkechi V EnwuruUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutical Microbiology and Biotechnology, Lagos, NigeriaORCID 0000-0003-2285-0682
Emmanuella AdenokunUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Lagos, NigeriaORCID 0000-0002-7538-8017
Abigail FatunmbiUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Lagos, NigeriaORCID 0000-0002-3778-8546
Adebowale AdeluolaUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutical Microbiology and Biotechnology, Lagos, NigeriaORCID 0000-0002-7235-6052
Cecilia I IgwiloUniversity of Lagos, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Lagos, NigeriaORCID 0000-0002-7950-7714
University of Lagos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Multi-drug resistant bacteria have been implicated in various debilitating infections that have led to life loss. This study developed an approach to tackle multidrug resistant Materials and Methods: Two isolates of Results: Two characterized Conclusion: Microparticle carrier technology was used to show the lytic activity against multi drug-resistant

Indexed as

chronic woundcytotoxicitymicroparticle hydrogelɸAB140 and ɸAB150 phage

Identifiers

PMID35510310
PMCPMC9083519
OpenAlexW3195400467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.